- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Cantor Fitzgerald
Recent news which mentions Cantor Fitzgerald
Which Canadian Cannabis Producer Is Best Positioned To Enter The US?
October 01, 2021
Tickers
CGC
From Benzinga
TLRY, CRLBF...Will Tilray Or Cresco Labs Grow More By 2022?
September 29, 2021
From Benzinga
New Jersey's Legal Cannabis Roll Out Could Face Delays: Will Neighboring States Benefit And Pull Ahead?
September 27, 2021
From Benzinga
Is Trulieve Still A Top Pick Ahead of $2B Harvest Health Merger?
September 22, 2021
From Benzinga
Canopy Growth's Exec Phil Shaer Steps Down As Head Of Legal Department
September 21, 2021
Tickers
CGC
From Benzinga
Canopy Growth's Stock Dips After Analyst Cuts Price On Lower Sales, Confesses Preference For Tilray
September 20, 2021
From Benzinga
Will Aurora Become A Global Medical Marijuana Leader? Analyst Opines Ahead Of Q4 Earnings
September 17, 2021
Tickers
ACB
From Benzinga
Why Should Cresco Labs Trade At A Premium To Its Peers?
September 09, 2021
Tickers
CRLBF
From Benzinga
Organigram On Pace To Beat Tilray And Hexo In QoQ Sales Growth As Canadian Rec. Sales Reach $275.6M
September 07, 2021
From Benzinga
From Benzinga
From Benzinga
Jushi Stock Might Be Worth The Same Today As One Year From Now
August 27, 2021
Tickers
JUSHF
From Benzinga
Trulieve Milestone: Opens 100th Cannabis Shop Nationwide, Gears Up Ahead Of Harvest Health Merger
August 25, 2021
From Benzinga
Why Are AYR Wellness And Verano Holdings Best Positioned For NJ's Recreational Cannabis Program?
August 24, 2021
From Benzinga
Should You Buy Trulieve Stock Before Its $2.1B Merger?
August 23, 2021
From Benzinga
Analyst Says MedMen's Momentum Changing, Tilray's Stake Won't Double Its Value But Will Hold Premium
August 18, 2021
From Benzinga
Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria
August 18, 2021
From Benzinga
Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization
August 13, 2021
From Benzinga
Cantor Fitzgerald Remains 'Neutral' On Sundial Growers After Earnings Report, Sees Potential Upside In Its 'CA$1B War Chest'
August 13, 2021
From Benzinga
Cantor: 'Aleafia Continues To Post Solid Momentum,' Firm Bullish But Lowers Price Target Due To Cannabis Sector Derating
August 12, 2021
Tickers
ALEAF
From Benzinga
Cantor Is Bullish On Trulieve's Q2 Financials, But Remains Cautious Of Possible Risks Ahead, Drops Price Target To $50
August 12, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.